Literature DB >> 9259368

Schizophrenia in the genetic isolate of Finland.

I Hovatta1, J D Terwilliger, D Lichtermann, T Mäkikyrö, J Suvisaari, L Peltonen, J Lönnqvist.   

Abstract

We compared the features of schizophrenia in the homogeneous population of Finland (population about 5,000,000) and in an internal isolate in northeastern Finland inhabited in the 1680s by a small group of founders (current population about 18,000) in a register-based epidemiological study. We identified all cases with a diagnosis of schizophrenia in Finland born between 1940-1969 using three national computerized registers and found a total of 267 schizophrenia patients in the internal isolate and 29,124 in Finland. The lifetime prevalence was 2.21% in the internal isolate and 1.21% in Finland, respectively. The age-corrected lifetime risk was 3.2% in the internal isolate and 1.1% in the whole country. The risk of schizophrenia to siblings in the internal isolate was 6.4% (95% confidence interval 0.052, 0.078), 9.1% (95% CI 0.062, 0.130), and 6.8% (95% CI 0.028, 0.135) given 1, 2, or 3 affected siblings, and for all Finland 4.2% (95% CI 0.036, 0.043), 6.4% (95% CI 0.058, 0.071), and 8.7% (95% CI 0.068, 0.107) given 1, 2, or 3, affected siblings, respectively. The mean number of children in schizophrenia families and thus the number of families having at least two affected individuals were clearly higher in the isolate (24.9% vs 9.2%). We did not find any other epidemiological features differing between these two regions. It seems that the family material collected from the internal isolate is a representative subsample from the entire country and hopefully it enables easier identification of at least some predisposing genes for schizophrenia due to its unique population structure.

Entities:  

Mesh:

Year:  1997        PMID: 9259368

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  25 in total

1.  Multiplex relative risk and estimation of the number of loci underlying an inherited disease.

Authors:  Paul Schliekelman; Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2002-11-21       Impact factor: 11.025

2.  Transgenic mice overexpressing the extracellular domain of NCAM are impaired in working memory and cortical plasticity.

Authors:  Leann H Brennaman; Gaga Kochlamazashvili; Luminita Stoenica; Randall J Nonneman; Sheryl S Moy; Melitta Schachner; Alexander Dityatev; Patricia F Maness
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

Review 3.  Genes and schizophrenia: beyond schizophrenia: the role of DISC1 in major mental illness.

Authors:  William Hennah; Pippa Thomson; Leena Peltonen; David Porteous
Journal:  Schizophr Bull       Date:  2006-05-12       Impact factor: 9.306

4.  Linkage analysis of schizophrenia controlling for population substructure.

Authors:  Tiina Paunio; Ritva Arajärvi; Joseph D Terwilliger; Tero Hiekkalinna; Perttu Haimi; Timo Partonen; Jouko Lönnqvist; Leena Peltonen; Teppo Varilo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

5.  The genome-wide patterns of variation expose significant substructure in a founder population.

Authors:  Eveliina Jakkula; Karola Rehnström; Teppo Varilo; Olli P H Pietiläinen; Tiina Paunio; Nancy L Pedersen; Ulf deFaire; Marjo-Riitta Järvelin; Juha Saharinen; Nelson Freimer; Samuli Ripatti; Shaun Purcell; Andrew Collins; Mark J Daly; Aarno Palotie; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2008-12       Impact factor: 11.025

6.  The Top3β way to untangle RNA.

Authors:  Alexi Nott; Li-Huei Tsai
Journal:  Nat Neurosci       Date:  2013-09       Impact factor: 24.884

7.  Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland.

Authors:  Sini Kerminen; Alicia R Martin; Jukka Koskela; Sanni E Ruotsalainen; Aki S Havulinna; Ida Surakka; Aarno Palotie; Markus Perola; Veikko Salomaa; Mark J Daly; Samuli Ripatti; Matti Pirinen
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

8.  Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia.

Authors:  Daniel Moreno-De-Luca; Jennifer G Mulle; Erin B Kaminsky; Stephan J Sanders; Scott M Myers; Margaret P Adam; Amy T Pakula; Nancy J Eisenhauer; Kim Uhas; LuAnn Weik; Lisa Guy; Melanie E Care; Chantal F Morel; Charlotte Boni; Bonnie Anne Salbert; Ashadeep Chandrareddy; Laurie A Demmer; Eva W C Chow; Urvashi Surti; Swaroop Aradhya; Diane L Pickering; Denae M Golden; Warren G Sanger; Emily Aston; Arthur R Brothman; Troy J Gliem; Erik C Thorland; Todd Ackley; Ram Iyer; Shuwen Huang; John C Barber; John A Crolla; Stephen T Warren; Christa L Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-11-04       Impact factor: 11.025

9.  Truncating mutations in RBM12 are associated with psychosis.

Authors:  Stacy Steinberg; Steinunn Gudmundsdottir; Gardar Sveinbjornsson; Jaana Suvisaari; Tiina Paunio; Minna Torniainen-Holm; Michael L Frigge; Gudrun A Jonsdottir; Johanna Huttenlocher; Sunna Arnarsdottir; Oddur Ingimarsson; Magnus Haraldsson; Thorarinn Tyrfingsson; Thorgeir E Thorgeirsson; Augustine Kong; Gudmundur L Norddahl; Daniel F Gudbjartsson; Engilbert Sigurdsson; Hreinn Stefansson; Kari Stefansson
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

10.  High concordance between self-reported medication and official prescription database information.

Authors:  Jari Haukka; Jaana Suvisaari; Annamari Tuulio-Henriksson; Jouko Lönnqvist
Journal:  Eur J Clin Pharmacol       Date:  2007-08-22       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.